$0.63
+0.02 (+2.77%)
Open$0.61
Previous Close$0.61
Day High$0.66
Day Low$0.60
52W High$2.69
52W Low$0.32
Volume—
Avg Volume371.6K
Market Cap20.27M
P/E Ratio—
EPS$-1.58
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
+6,371.2% upside
Current
$0.63
$0.63
Target
$40.51
$40.51
$28.40
$40.51 avg
$50.89
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 6.30M | 6.48M | 4.92M |
| Net Income | -1,316,650 | -1,573,823 | -1,131,717 |
| Profit Margin | -20.9% | -24.3% | -23.0% |
| EBITDA | -2,363,922 | -2,326,744 | -1,866,701 |
| Free Cash Flow | -1,722,588 | -1,580,767 | -1,263,847 |
| Rev Growth | -2.8% | +6.4% | +0.2% |
| Debt/Equity | 0.17 | 0.14 | 0.19 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |